CVS chooses Amgen's new cholesterol drug over competitor

NEW YORK (Reuters) - U.S. drug benefit manager CVS Health said on Monday it would add Amgen Inc's Repatha cholesterol treatment to its list of covered drugs for private plans over a competing treatment from Regeneron Pharmaceuticals and Sanofi SA.